Platelet-rich fibrin (PRF): a second-generation platelet concentrate. Part IV: clinical effects on tissue healing.

By J. Choukroun, A. Diss, Alain Simonpieri, M. Girard, C. Schoeffler, Steve L Dohan, A. Dohan, J. Mouhyi, D. Dohan. Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics, 2006

1,294 citations recorded by the source corpus.

Subfields: Oral Surgery, Pharmacy, Urology

View Paper: https://www.semanticscholar.org/paper/84e21f458b58a775f75c07baa3f12d23d0add6ba

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Urology

1. P. Doglioli
2. D. M. Dohan Ehrenfest
3. G. Sammartino
4. G. M. de Peppo

Citations in the corpus

• Slow release of growth factors and thrombospondin-1 in Choukroun's platelet-rich fibrin (PRF): a gold standard to achieve for all surgical platelet concentrates technologies (2009, background): “When delicately pressed between two gauzes, the PRF clot becomes a strong membrane with high potential, both in clinical application (Choukroun et al. 2006a, 2006b; Braccini and Dohan 2007; Saadoun and Touati 2007; Diss et al. 2008) and tissue engineering (Choukroun et al. 2007; Figure 1).”